Andy May

Andy May is a Scientific Advisor at Serotiny. Andy was previously the Chief Technology Officer at Sana Biotechnology, Inc. from October 2018 to February 2020. Prior to that, they were the Senior Director, Genome Engineering at CZ Biohub from February 2017 to October 2018. From October 2013 to January 2017, they were the Chief Scientific Officer at Caribou Biosciences. Andy has also worked as an independent consultant and as a director, R&D for Fluidigm Corporation. Andy has a Ph.D. in Molecular Biology from Stanford University.

Andy May earned a MA in Chemistry from the University of Oxford and a DPhil in Molecular Biophysics from the University of Oxford.